<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00874952</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-CIT-DUM-2007/1</org_study_id>
    <nct_id>NCT00874952</nct_id>
  </id_info>
  <brief_title>Regional Observation of the Metabolic Syndrome</brief_title>
  <acronym>ORSA</acronym>
  <official_title>Regional Observation of the Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study, is to assess the prevalence of metabolic syndrome in Italy on a
      regional basis, defined according to National Cholesterol Education Program/Adult Treatment
      Panel III (NCEP/ATPIII) guidelines criteria.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of metabolic syndrome in primary care population</measure>
    <time_frame>At visit</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Concomitant presence of other cardiovascular (CV) risk factors.</measure>
    <time_frame>At visit</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">1600</enrollment>
  <condition>Metabolic Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent

          -  Laboratory analysis (lipidic profile and glycemia) performed in the last year

        Exclusion Criteria:

          -  Subjects with serious or unstable medical or psychological conditions that, in the
             opinion of the investigator, would compromise the subject's successful participation
             in the study

          -  Pregnancy or breast feeding

          -  Patients enrolled in clinical studies which the aim is to evaluate the efficacy and/or
             tolerability of anti-hypertensive and/or lipid lowering drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mario Mangrella</last_name>
    <role>Study Chair</role>
    <affiliation>AstraZeneca S.p.A.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raffaele Sabia</last_name>
    <role>Study Director</role>
    <affiliation>AstraZeneca S.p.A.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 2, 2009</study_first_submitted>
  <study_first_submitted_qc>April 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 3, 2009</study_first_posted>
  <last_update_submitted>February 16, 2010</last_update_submitted>
  <last_update_submitted_qc>February 16, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2010</last_update_posted>
  <responsible_party>
    <name_title>Raffaele Sabia/MC MD</name_title>
    <organization>AstraZeneca</organization>
  </responsible_party>
  <keyword>Metabolic syndrome</keyword>
  <keyword>Lipids</keyword>
  <keyword>Waist Circumference</keyword>
  <keyword>HDL</keyword>
  <keyword>hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

